OR WAIT null SECS
December 05, 2022
Andrew S. Morgenstern, OD, FAAO, FNAP, highlights the importance of reducing pupil size to a certain level to optimize near vision for patients with presbyopia.
Expert eye care specialists discuss the role of miotic agents in targeting presbyopia in patients.
Sean W. Smolenyak, OD, gives a brief overview of presbyopia, including the cause and available treatments.
November 23, 2022
Drs Andrew S. Morgenstern and Francis S. Mah provide insight on the functionality of ocular accommodation as an autofocus lens and how this is affected in patients with presbyopia.
Francis S. Mah, MD, and Andrew S. Morgenstern, OD, FAAO, FNAP, review the impact of presbyopia on quality of life as well as current treatment options and unmet needs for disease management.
November 08, 2022
Ocuphire seeks to develop and commercialize Nyxol for the reversal of mydriasis, presbyopia and night vision disturbances.
October 30, 2022
Erin Rueff, OD, PhD, FAAO, shares highlights from her 2022 American Academy of Optometry presentations in the contact lens space.
October 25, 2022
Presbyopia-correcting drops for patients with low, up-close visual function.
October 19, 2022
Evolution of vision correction procedures, diagnostics paves way for collaborative care.
October 13, 2022
World Sight Day is upon us and RestoringVision has issued a lofty but doable goal: help solve the global vision crisis.
Getting started: methods of initial scleral lens selection
What is presbyopia?
Case report: Combination treatment proves effective for choroidal metastasis from breast cancer patient
Alcon completes acquisition of Aerie Pharmaceuticals
